{"id":12269,"date":"2026-08-25T09:24:19","date_gmt":"2026-08-25T07:24:19","guid":{"rendered":"https:\/\/www.aieop.org\/web\/?p=12269"},"modified":"2026-08-25T09:24:19","modified_gmt":"2026-08-25T07:24:19","slug":"comunicazione-inserimento-del-medicinale-brigatinib-nellelenco-dei-farmaci-erogati-in-accordo-alla-legge-648-1996","status":"publish","type":"post","link":"https:\/\/www.aieop.org\/web\/comunicazione-inserimento-del-medicinale-brigatinib-nellelenco-dei-farmaci-erogati-in-accordo-alla-legge-648-1996\/","title":{"rendered":"Comunicazione inserimento del medicinale brigatinib nell&#8217;elenco dei farmaci erogati in accordo alla Legge 648\/1996"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 blog-article nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-right:120px;--awb-padding-left:120px;--awb-margin-top:60px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"--awb-bg-size:cover;--awb-margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\"><div class=\"fusion-title title fusion-title-1 fusion-title-text fusion-title-size-two\"><h2 class=\"fusion-title-heading title-heading-left\" style=\"margin:0;\">Comunicazione inserimento del medicinale brigatinib nell&#8217;elenco dei farmaci erogati in accordo alla Legge 648\/1996<\/h2><span class=\"awb-title-spacer\"><\/span><div class=\"title-sep-container\"><div class=\"title-sep sep-double sep-solid\" style=\"border-color:#e0dede;\"><\/div><\/div><\/div><div class=\"fusion-text fusion-text-1\"><p>Con determina AIFA del 28 luglio 2026, inserita nella Gazzetta Ufficiale del 6 agosto 2026, il medicinale brigatinib\u00a0 (Alunbrig)\u00a0 \u00e8 inserito nell\u2019elenco dei farmaci erogabili a totale carico del Servizio sanitario nazionale ai sensi della Legge 648\/1996 con la seguente indicazione \u201cTrattamento\u00a0 di\u00a0 meningiomi\u00a0 del\u00a0 sistema\u00a0 nervoso\u00a0 centrale\u00a0 \u00a0in progressione\u00a0 clinica\u00a0 o\u00a0 \u00a0radiologica\u00a0 \u00a0in\u00a0 \u00a0pazienti\u00a0 \u00a0affetti\u00a0 \u00a0da schwannomatosi NF2-correlata\u201d e nel rispetto delle condizioni\u00a0 indicate nell&#8217;allegato 1, parte integrante della determina.<\/p>\n<p>Link per accesso alla determina:<\/p>\n<p><a href=\"https:\/\/www.gazzettaufficiale.it\/eli\/id\/2026\/08\/06\/26A03973\/sg\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.gazzettaufficiale.it\/eli\/id\/2026\/08\/06\/26A03973\/sg&amp;source=gmail&amp;ust=1787728790105000&amp;usg=AOvVaw1G5jLyAAir0kzcUzMye-Om\">https:\/\/www.gazzettaufficiale.<wbr \/>it\/eli\/id\/2026\/08\/06\/26A03973\/<wbr \/>sg<\/a>&lt;<a href=\"https:\/\/urlsand.esvalabs.com\/?u=https%3A%2F%2Fwww.gazzettaufficiale.it%2Feli%2Fid%2F2026%2F08%2F06%2F26A03973%2Fsg&amp;e=a39aa7eb&amp;h=581d41f1&amp;f=y&amp;p=y&amp;m=4hT4h833CHzFpZq\" target=\"_blank\" rel=\"noopener noreferrer\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/urlsand.esvalabs.com\/?u%3Dhttps%253A%252F%252Fwww.gazzettaufficiale.it%252Feli%252Fid%252F2026%252F08%252F06%252F26A03973%252Fsg%26e%3Da39aa7eb%26h%3D581d41f1%26f%3Dy%26p%3Dy%26m%3D4hT4h833CHzFpZq&amp;source=gmail&amp;ust=1787728790105000&amp;usg=AOvVaw3YHcYMDnhCoY1v3eO79SMd\">https:\/\/urlsand.esvalabs.co<wbr \/>m\/?u=https%3A%2F%2Fwww.gazzett<wbr \/>aufficiale.it%2Feli%2Fid%<wbr \/>2F2026%2F08%2F06%2F26A03973%<wbr \/>2Fsg&amp;e=a39aa7eb&amp;h=581d41f1&amp;f=<wbr \/>y&amp;p=y&amp;m=4hT4h833CHzFpZq<\/a>&gt;<\/p>\n<\/div><div class=\"fusion-text fusion-text-2\"><p><a href=\"https:\/\/www.aieop.org\/web\/wp-content\/uploads\/2026\/08\/Comunicazione-determina-AIFA-inserimento-brigatinib-648-1996_signed.pdf\" target=\"_blank\" rel=\"noopener\">Comunicazione determina AIFA &#8211; inserimento brigatinib 648-1996<\/a><\/p>\n<\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-12269","post","type-post","status-publish","format-standard","hentry","category-in-evidenza"],"_links":{"self":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/12269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/comments?post=12269"}],"version-history":[{"count":1,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/12269\/revisions"}],"predecessor-version":[{"id":12272,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/posts\/12269\/revisions\/12272"}],"wp:attachment":[{"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/media?parent=12269"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/categories?post=12269"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aieop.org\/web\/wp-json\/wp\/v2\/tags?post=12269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}